Rachel Jenkins - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Rachel Jenkins's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Rachel Jenkins
Verified
Senior Editor, Oncology Central
London
Beats
Healthy lifestyle habits and products specializing in plant-based living.
Fluff
Content
Plain language summary and patient perspective of the ESMO expert consensus statements on treating EGFR-positive NSCLC
By Rachel Jenkins, Joanne Walker Verified, Upal Basu Roy, Jade Parker| Oncology Central Verified Future Oncology, our partner journal, has recently published a Plain Language Summary of Publication and patient perspective of the ESMO expert consensus statements on treating EGFR-positive NSCLC. Read the Plain Language Summary hereAbstractWhat is this summary about? This article provides a plain language summary and patient perspective of a new set of recommendations made by the European Society for Medical Oncology (ESMO for short).
Plain language summary and patient perspective: 2020 lung cancer screening recommendations by the US Preventive Services Task Force
By Rachel Jenkins, Joanne Walker Verified, Upal Basu Roy, Jill Feldman| Oncology Central Verified Future Oncology, our partner journal, has recently published a Plain Language Summary of Publication and patient perspective of the United States Preventive Services Task Force’s lung cancer screening recommendations. Read the Plain Language Summary hereAbstractWhat is this summary about? This summary describes the research carried out by the United States Preventive Services Task Force (USPSTF for short) during a review and update of their lung cancer screening recommendations made in 2013.
Plain language summary and patient perspective of the ESMO expert consensus statements on treating EGFR-positive NSCLC
By Rachel Jenkins, Joanne Walker Verified, Upal Basu Roy, Jade Parker| Oncology Central Verified Future Oncology, our partner journal, has recently published a Plain Language Summary of Publication and patient perspective of the ESMO expert consensus statements on treating EGFR-positive NSCLC. Read the Plain Language Summary hereAbstractWhat is this summary about? This article provides a plain language summary and patient perspective of a new set of recommendations made by the European Society for Medical Oncology (ESMO for short).
Company Info
Oncology Central
Oncology Central, part of Taylor Francis, is a free online platform that is dedicated to advancing oncology by offering access to trusted, engaging and insightful resources – including breaking news, peer-reviewed articles, webinars and articles from key opinion leaders. By providing 360° perspectives on the latest advancements – encompassing the viewpoints of industry, clinicians, researchers, charities and patients alike – we are very proud to have established Oncology Central as a key resource for the global oncology community.
London, United Kingdom
+44 20 8371 6090